Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
588.00    9.00 (1.55%)
Bid:
586.00
Ask:
589.00
Spread: 3.00 (0.512%)
Market Cap: £854.90m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Prospectus

11 Sep 2020 13:03

RNS Number : 7873Y
SAGA PLC
11 September 2020
 

NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, NEW ZEALAND, OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT BUT AN ADVERTISEMENT. INVESTORS SHOULD NOT SUBSCRIBE FOR, OR OTHERWISE PURCHASE, ACQUIRE, SELL OR DISPOSE OF, ANY OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF THE INFORMATION CONTAINED IN AND INCORPORATED BY REFERENCE INTO THE PROSPECTUS PUBLISHED BY THE COMPANY.

11 September 2020

Saga plc

 

Publication of combined prospectus and circular

 

Further to the announcement yesterday by Saga plc (the "Company" or "Saga") relating to its intention to raise £150 million in equity capital (the "Capital Raising"), the Company has published a combined prospectus and circular which has been approved by the Financial Conduct Authority (the "Prospectus") in connection with the Company's proposed Capital Raising.

The Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Prospectus is also available for inspection on the Company's website: www.corporate.saga.co.uk

The defined terms set out in the Prospectus apply in this announcement.

 

 

For further information, please contact:

Saga plc

Investor Relations

 

Mark Watkins

 

Tel: +44 (0) 203 846 5113

 

 

 

Sponsor, Joint Global Coordinator and Joint Bookrunner

 

J.P. Morgan Cazenove

Edward Squire, James A. Kelly, Andrew Stockdale

Tel: +44 (0) 207 742 4000

Joint Global Coordinator and Joint Bookrunner

 

Numis

Charles Farquhar, Stephen Westgate, Jamie Loughborough

Tel: + 44 (0) 20 7260 1000

Joint Bookrunner

 

HSBC

Anthony Parsons, Richard Fagan, Graeme Lewis

Tel: +44 (0) 20 7991 8888

 

 

 

 

 

Media Enquiries

 

 

Headland Consultancy

Susanna Voyle, Henry Wallers, Sophie O'Donoghue

 

Tel: +44 (0) 203 805 4822

 

IMPORTANT NOTICE

This announcement has been issued by and is the sole responsibility of the Company. This announcement is not a prospectus or prospectus equivalent but an advertisement and investors should not subscribe for, or otherwise purchase, acquire, sell or dispose of any of the securities referred to in this announcement except on the basis of the information contained in the Prospectus. The information contained in this announcement is for background purposes only and does not purport to be full or complete. A copy of the Prospectus will shortly be available on the Company's website, provided that the Prospectus will not, subject to certain exceptions, be available to certain Shareholders in certain restricted or excluded territories. The Prospectus will give further details of the Capital Raising.

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities of the Company (the "Securities"), or the solicitation of any vote or approval in, the United States (including its territories and possessions, any state of the United States and the District of Columbia) (the "United States" or "US") or in any other jurisdiction, pursuant to this announcement or otherwise. Any offer, if made, will be made solely by certain offer documentation which will contain the full terms and conditions of any offer, including details of how it may be accepted. The distribution of this announcement in jurisdictions other than the UK and the availability of any offer to Shareholders of Saga who are not resident in the UK may be affected by the laws of relevant jurisdictions. Therefore, any persons who are subject to the laws of any jurisdiction other than the UK or Shareholders of Saga who are not resident in the UK will need to inform themselves about and observe any applicable requirements.

The Securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States, and accordingly may not be offered, sold, pledged or transferred, directly or indirectly, in, into or within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any relevant state or jurisdiction of the United States. There will be no public offering of Securities in the United States and there is no intention to register any portion of any offering in the United States.

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove") and HSBC Bank plc ("HSBC") each of which is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated by the PRA and the Financial Conduct Authority (the "FCA"), and Numis Securities Limited ("Numis", and together with J.P. Morgan Cazenove and HSBC, the "Joint Bookrunners"), which is authorised and regulated in the United Kingdom by the FCA, are each acting exclusively for Saga and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Saga for providing the protections afforded to their clients or affiliates, or for providing advice in relation to any matter or arrangement referred to herein.

None of the Joint Bookrunners nor any of their respective affiliates (or any of their respective directors, officers, employees or advisers) accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy, fairness, sufficiency or completeness of the information or the opinions or beliefs contained in this announcement (or any part hereof). None of the information in this announcement has been independently verified or approved by the Joint Bookrunners or any of their respective affiliates. The Joint Bookrunners and each of their respective affiliates (and their respective directors, officers, employees or advisers) accordingly disclaim all and any liability, whether arising in tort, contract or in respect of any statements or other information contained in this announcement and no representation or warranty, express or implied, is made by either a Joint Bookrunner or any of their respective affiliates (or any of their respective directors, officers, employees or advisers) as to the accuracy, completeness or sufficiency of the information contained in this announcement. Save in the case of fraud, no responsibility or liability is accepted by the Joint Bookrunners or any of their respective affiliates (or any of their respective directors, officers, employees or advisers) for any errors, omissions or inaccuracies in such information or opinions or for any loss, cost or damage suffered or incurred howsoever arising, directly or indirectly, from any use of this announcement or its contents or otherwise in connection with this announcement. No person has been authorised to give any information or to make any representations other than those contained in this announcement and, if given or made, such announcements must not be relied on as having been authorised by the Company, the Joint Bookrunners or any of their respective affiliates. Subject to the Listing Rules, the Prospectus Regulation Rules, the Disclosure Guidance and Transparency Rules and MAR, the issue of this announcement and any subsequent announcement shall not, in any circumstances, create any implication that there has been no change in the affairs of the Group since the date of this announcement or that the information contained in it is correct as at any subsequent date.

This announcement contains "forward-looking statements", which include statements other than statements of historical facts, including, without limitation, those regarding the Company's intentions, beliefs or current expectations concerning, among other things, its future financial condition and performance and results of operations; its strategy, plans, objectives, prospects, growth, goals and targets; future developments in the industry and markets in which the Company participates or is seeking to participate; and anticipated regulatory changes in the industry and markets in which the Company operates. In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "project", "should" or "will" or, in each case, their negative, or other variations or comparable terminology. By their nature, forward-looking statements are subject to known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Such forward-looking statements are based on numerous assumptions, some of which are outside of the Company's influence and/or control, regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. Shareholders and potential investors are cautioned that forward-looking statements are not guarantees of future performance and that the Company's actual financial condition, results of operations, cash flows and distributions to Shareholders and the development of its financing strategies, and the development of the industry in which it operates, may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the Company's financial condition, results of operations, cash flows and distributions to Shareholders and the development of their financing strategies, and the development of the industry in which they operate, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods. No statement in this announcement is intended to be a profit forecast.

 

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIGPUUUBUPUGPG
Date   Source Headline
26th May 20269:00 amRNSNotice of AGM/ Annual Report and Accounts
12th May 20264:23 pmRNSTotal Voting Rights
8th May 202611:45 amRNSIssue of Equity
23rd Apr 20264:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20264:40 pmRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSPreliminary results for the year ended 31 Jan 2026
23rd Mar 20261:59 pmRNSCommittee Changes
3rd Mar 20267:00 amRNSAppointment of Joint Corporate Brokers
27th Feb 20264:00 pmRNSDirectorate change
29th Jan 20267:00 amRNSTrading Update
16th Dec 20257:00 amRNSSaga and Ageas Insurance partnership goes live
30th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 202510:15 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNS2025-26 interim results statement
15th Jul 20259:00 amRNSTotal Voting Rights
14th Jul 20257:00 amRNSSaga Money launches partnership with NatWest
9th Jul 202512:00 pmRNSCommittee changes
9th Jul 202511:49 amRNSIssue of Equity
1st Jul 20253:57 pmRNSHolding(s) in Company
1st Jul 20252:09 pmRNSAcromas Insurance Company Limited Completion
26th Jun 20251:49 pmRNSDirector/PDMR Shareholding
24th Jun 20251:13 pmRNSResult of AGM
24th Jun 20259:02 amRNSDirector Declaration
24th Jun 20257:00 amRNSAGM Trading Update
29th May 20252:38 pmRNSDirector/PDMR Shareholding
20th May 20259:00 amRNSNotice of AGM
11th Apr 202511:00 amRNSHolding(s) in Company
10th Apr 20257:30 amRNSDirector/PDMR Shareholding
9th Apr 20253:54 pmRNSDirector/PDMR Shareholding
9th Apr 20257:01 amRNSDirectorate Change
9th Apr 20257:00 amRNSFinal Results
13th Mar 20258:00 amRNSDirector Declaration
28th Feb 20257:00 amRNSRepayment of corporate debt and new draw down
12th Feb 20258:00 amRNSDirector Declaration
30th Jan 20257:01 amRNSTrading Update
30th Jan 20257:00 amRNSSaga successfully refinances corporate debt
16th Dec 20247:00 amRNSSaga and Ageas agree new Insurance partnership
10th Dec 20243:57 pmRNSDirector Declaration
24th Oct 20247:35 amRNSCorrection - Director Declaration
24th Oct 20247:35 amRNSDirector Declaration
11th Oct 20247:00 amRNSInterim results for the six months ended 31 July
11th Oct 20247:00 amRNSSaga and Ageas in exclusive negotiations
2nd Oct 20247:00 amRNSResponse to Media Coverage
1st Oct 20244:23 pmRNSDelay to publication of H1 2024 results
1st Oct 20248:59 amRNSDirector Declaration
9th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 20243:00 pmRNSCorrection - Result of AGM
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.